Stocks and Investing
Stocks and Investing
Fri, December 9, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, December 8, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Frank Takkinen Initiated (APYX) at Strong Buy and Held Target at $5 on, Dec 8th, 2022
Frank Takkinen of Lake Street, Initiated "Apyx Medical Corporation" (APYX) at Strong Buy and Held Target at $5 on, Dec 8th, 2022.
Frank has made no other calls on APYX in the last 4 months.
There is 1 other peer that has a rating on APYX. Out of the 1 peers that are also analyzing APYX, 0 agree with Frank's Rating of Hold.
This is the rating of the analyst that currently disagrees with Frank
- Matt O'Brien of "Piper Sandler" Maintained at Buy with Increased Target to $12 on, Friday, August 12th, 2022
Contributing Sources